Skip to content

Research on subchondral micro-perfusion and Tongluo Qubi therapy in knee osteoarthritis

Research on subchondral micro-perfusion and Tongluo Qubi therapy in knee osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004727
Enrollment
Unknown
Registered
2014-03-01
Start date
2014-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

Jingui external lotion group:fumigating and washing with Jingui external lotion
Simulative external lotion group:Simulative placebo external lotion

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for knee osteoarthritis aged 50 to 80 years; (2) the Kellgren-Lawrence grading system shown Grade 3 or 4narrowing in medial joint space,received conservative treatment; (3) without serious medical history, without any severe vascular lesions on lower limbs; (4) without any study drug allergy, including contrast agent, no MRI contraindications; (5) volunteered for the researchers.

Exclusion criteria

Exclusion criteria: (1) have MRI contraindications,study drug allergy; (2) none degenerative osteoarthritis, such as rheumatoid arthritis, gouty arthritis, infectious arthritis, charcot arthritis, etc; (3) can't stop using painkillers; (4) fail to complete the course of treatment; (5) failed to obtain informed consent.

Design outcomes

Primary

MeasureTime frame
American knee society knee score;tender point Visual Analogue Scale;enhanced rate in subchondral interesting regions;maximum upslope in subchondral interesting regions;enhancement rate of anterior and posterior periarticu synovial membrane;

Contacts

Public ContactDa Guo

Guangdong Provincial Hospital of Chinese Medicine

341127403@qq.com+86 13926464394

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 5, 2026